Page last updated: 2024-08-25

5-(3-methyl-1-triazeno)imidazole-4-carboxamide and aminoimidazole carboxamide

5-(3-methyl-1-triazeno)imidazole-4-carboxamide has been researched along with aminoimidazole carboxamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alton, K; Baker, SD; Batra, V; Cutler, D; Donehower, RC; Dugan, M; Grochow, LB; Reidenberg, P; Rowinsky, EK; Sartorius, SE; Statkevich, P; Wirth, M1

Trials

1 trial(s) available for 5-(3-methyl-1-triazeno)imidazole-4-carboxamide and aminoimidazole carboxamide

ArticleYear
Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:2

    Topics: Absorption; Administration, Oral; Adult; Aged; Aminoimidazole Carboxamide; Antineoplastic Agents, Alkylating; Blood Proteins; Carbon Radioisotopes; Dacarbazine; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Temozolomide

1999